A Quantitative Process for Enhancing End of Phase 2 Decisions. (2014)
Attributed to:
MRC Clinical Trials Unit as the London Hub for Trials Methodology Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/19466315.2013.852617
PubMed Identifier: 24683441
Publication URI: http://europepmc.org/abstract/MED/24683441
Type: Journal Article/Review
Volume: 6
Parent Publication: Statistics in biopharmaceutical research
Issue: 1
ISSN: 1946-6315